119 related articles for article (PubMed ID: 36413597)
1. Characterization of TGF-β signaling in a human organotypic skin model reveals that loss of TGF-βRII induces invasive tissue growth.
Ye Z; Kilic G; Dabelsteen S; Marinova IN; Thøfner JFB; Song M; Rudjord-Levann AM; Bagdonaite I; Vakhrushev SY; Brakebusch CH; Olsen JV; Wandall HH
Sci Signal; 2022 Nov; 15(761):eabo2206. PubMed ID: 36413597
[TBL] [Abstract][Full Text] [Related]
2. Epidermal Growth Factor Stimulates Transforming Growth Factor-Beta Receptor Type II Expression In Corneal Epithelial Cells.
Shu DY; Hutcheon AEK; Zieske JD; Guo X
Sci Rep; 2019 May; 9(1):8079. PubMed ID: 31147562
[TBL] [Abstract][Full Text] [Related]
3. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
5. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
Guo H; Zhang HY; Wang SL; Ye L; Yang GH; Bu H
Chin Med J (Engl); 2007 Mar; 120(6):515-21. PubMed ID: 17439748
[TBL] [Abstract][Full Text] [Related]
6. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].
Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
8. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
9. [Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer].
Lu B; Zhou YN; Li Q; Wu ZQ; Zhang ZY; Ji R; Guo QH; Liu W
Ai Zheng; 2009 May; 28(5):538-42. PubMed ID: 19624886
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling.
Paus R; Foitzik K; Welker P; Bulfone-Paus S; Eichmüller S
J Invest Dermatol; 1997 Oct; 109(4):518-26. PubMed ID: 9326384
[TBL] [Abstract][Full Text] [Related]
11. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.
Horowitz JC; Lee DY; Waghray M; Keshamouni VG; Thomas PE; Zhang H; Cui Z; Thannickal VJ
J Biol Chem; 2004 Jan; 279(2):1359-67. PubMed ID: 14576166
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of TGF-β1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b.
Witte D; Otterbein H; Förster M; Giehl K; Zeiser R; Lehnert H; Ungefroren H
Sci Rep; 2017 Dec; 7(1):17313. PubMed ID: 29229918
[TBL] [Abstract][Full Text] [Related]
13. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4.
Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y
Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607
[TBL] [Abstract][Full Text] [Related]
15. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
[TBL] [Abstract][Full Text] [Related]
18. GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5/TGF-βRII heterodimer.
Artz A; Butz S; Vestweber D
Blood; 2016 Jul; 128(4):529-41. PubMed ID: 27235139
[TBL] [Abstract][Full Text] [Related]
19. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.
Ungefroren H; Lenschow W; Chen WB; Faendrich F; Kalthoff H
J Biol Chem; 2003 Mar; 278(13):11041-9. PubMed ID: 12538652
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.
Saha D; Datta PK; Beauchamp RD
J Biol Chem; 2001 Aug; 276(31):29531-7. PubMed ID: 11371552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
